CNBX Pharmaceuticals Inc. SEC filings CNBX
CNBX Pharmaceuticals Inc. has 301 filings in SEC EDGAR's recent list, going back to Jan 9, 2006. Its latest annual report, Form 10-K, was filed on Dec 1, 2025 for the period ended Aug 31, 2025. The latest quarterly report (Form 10-Q) was filed on Jun 24, 2026, covering the quarter ended May 31, 2026. The most recent current report (Form 8-K) was filed on Oct 1, 2026 (auditor change). The company's fiscal year ends on August 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Auditor change
|
Oct 1, 2026 | Sep 28, 2026 |
| 10-Q | Quarterly report | Jun 24, 2026 | May 31, 2026 |
| 10-Q | Quarterly report | Apr 14, 2026 | Feb 28, 2026 |
| 8-K |
Current report
Material agreement
|
Mar 17, 2026 | Mar 10, 2026 |
| 10-Q | Quarterly report | Jan 14, 2026 | Nov 30, 2025 |
| 10-K | Annual report | Dec 1, 2025 | Aug 31, 2025 |
| 10-Q | Quarterly report | Jul 14, 2025 | May 31, 2025 |
| 10-Q | Quarterly report | Apr 14, 2025 | Feb 28, 2025 |
| 8-K |
Current report
Material agreement
|
Jan 30, 2025 | Jan 24, 2025 |
| 10-Q | Quarterly report | Jan 13, 2025 | Nov 30, 2024 |
| 10-K | Annual report | Nov 29, 2024 | Aug 31, 2024 |
| 10-Q | Quarterly report | Jul 15, 2024 | May 31, 2024 |
| UPLOAD | Letter from the SEC | Jun 17, 2024 | — |
| CORRESP | Letter to the SEC | Jun 6, 2024 | — |
| UPLOAD | Letter from the SEC | May 30, 2024 | — |
| CORRESP | Letter to the SEC | May 21, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 22, 2024 | — |
| 10-Q | Quarterly report | Apr 16, 2024 | Feb 29, 2024 |
| NT 10-Q | Extension | Apr 15, 2024 | Feb 29, 2024 |
| CORRESP | Letter to the SEC | Apr 10, 2024 | — |
| 8-K |
Current report
Auditor change
|
Mar 22, 2024 | Mar 18, 2024 |
| UPLOAD | Letter from the SEC | Jan 29, 2024 | — |
| 10-Q | Quarterly report | Jan 12, 2024 | Nov 30, 2023 |
| 10-K | Annual report | Nov 30, 2023 | Aug 31, 2023 |
| 10-Q | Quarterly report | Jul 14, 2023 | May 31, 2023 |
| 10-Q | Quarterly report | Apr 14, 2023 | Feb 28, 2023 |
| 8-K |
Current report
Officer or director change
|
Feb 8, 2023 | Jan 31, 2023 |
| 10-Q | Quarterly report | Jan 13, 2023 | Nov 30, 2022 |
| 8-K |
Current report
Officer or director change
|
Dec 29, 2022 | Dec 25, 2022 |
| RW | Registration withdrawl | Dec 27, 2022 | — |
| 10-K | Annual report | Nov 30, 2022 | Aug 31, 2022 |
| 8-K |
Current report
Officer or director change
|
Jul 25, 2022 | Jul 20, 2022 |
| 10-Q | Quarterly report | Jul 14, 2022 | May 31, 2022 |
| 8-K |
Current report
Bylaw or fiscal year change
|
May 13, 2022 | May 10, 2022 |
| 10-Q | Quarterly report | Apr 12, 2022 | Feb 28, 2022 |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Mar 28, 2022 | Mar 28, 2022 |
| 8-K |
Current report
Material agreement, New debt
|
Mar 16, 2022 | Mar 11, 2022 |
| S-1 | Registration statement | Feb 18, 2022 | — |
| 8-K |
Current report
Material agreement
|
Feb 17, 2022 | Feb 15, 2022 |
| DEF 14C | Information statement | Feb 15, 2022 | Feb 14, 2022 |
| PRE 14C | Preliminary information statement | Feb 4, 2022 | Feb 28, 2022 |
| 10-Q | Quarterly report | Jan 13, 2022 | Nov 30, 2021 |
| 10-K | Annual report | Nov 29, 2021 | Aug 31, 2021 |
| 8-K |
Current report
Officer or director change
|
Nov 19, 2021 | Nov 16, 2021 |
| 8-K |
Current report
Officer or director change
|
Sep 13, 2021 | Sep 3, 2021 |
| 8-K |
Current report
Officer or director change
|
Jul 19, 2021 | Jul 15, 2021 |
| 10-Q | Quarterly report | Jul 14, 2021 | May 31, 2021 |
| 8-K |
Current report
Officer or director change
|
Jul 6, 2021 | Jul 1, 2021 |
| EFFECT | Filing | May 17, 2021 | — |
| UPLOAD | Letter from the SEC | May 14, 2021 | — |
| CORRESP | Letter to the SEC | May 14, 2021 | — |
| S-1 | Registration statement | May 10, 2021 | — |
| 8-K |
Current report
Material agreement
|
Apr 28, 2021 | Apr 23, 2021 |
| 10-Q | Quarterly report | Apr 14, 2021 | Feb 28, 2021 |
| EFFECT | Filing | Mar 11, 2021 | — |
| CORRESP | Letter to the SEC | Mar 10, 2021 | — |
| CORRESP | Letter to the SEC | Mar 9, 2021 | — |
| UPLOAD | Letter from the SEC | Mar 8, 2021 | — |
| CORRESP | Letter to the SEC | Feb 23, 2021 | — |
| S-1/A | Amended registration statement | Feb 23, 2021 | — |
| UPLOAD | Letter from the SEC | Feb 9, 2021 | — |
| S-1 | Registration statement | Jan 27, 2021 | — |
| 10-Q | Quarterly report | Jan 14, 2021 | Nov 30, 2020 |
| 8-K |
Current report
Material agreement
|
Dec 21, 2020 | Dec 16, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 16, 2020 | Nov 16, 2020 |
| 10-K | Annual report | Nov 4, 2020 | Aug 31, 2020 |
| 8-K |
Current report
Officer or director change
|
Sep 2, 2020 | Sep 2, 2020 |
| 10-Q | Quarterly report | Jul 14, 2020 | May 31, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 17, 2020 | Apr 16, 2020 |
| 8-K |
Current report
Officer or director change
|
Apr 17, 2020 | Apr 16, 2020 |
| 10-Q | Quarterly report | Apr 13, 2020 | Feb 29, 2020 |
| 10-Q | Quarterly report | Jan 14, 2020 | Nov 30, 2019 |
| 10-K | Annual report | Nov 29, 2019 | Aug 31, 2019 |
| 8-K |
Current report
Change in control
|
Nov 8, 2019 | Nov 6, 2019 |
| 8-K |
Current report
Auditor change
|
Nov 7, 2019 | Nov 6, 2019 |
| 8-K |
Current report
Officer or director change
|
Oct 11, 2019 | Oct 7, 2019 |
| 8-K |
Current report
Officer or director change
|
Oct 7, 2019 | Oct 7, 2019 |
| 8-K |
Current report
Officer or director change
|
Oct 3, 2019 | Oct 2, 2019 |
| 8-K |
Current report
Auditor change
|
Jul 23, 2019 | Jul 21, 2019 |
| 10-Q | Quarterly report | Jul 15, 2019 | May 31, 2019 |
| 8-K |
Current report
Officer or director change
|
Jun 25, 2019 | Jun 21, 2019 |
| 10-Q | Quarterly report | Apr 15, 2019 | Feb 28, 2019 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Feb 13, 2019 | Feb 7, 2019 |
| 10-Q | Quarterly report | Jan 17, 2019 | Nov 30, 2018 |
| NT 10-Q | Notice of late filing | Jan 14, 2019 | Nov 30, 2018 |
| 10-K | Annual report | Nov 29, 2018 | Aug 31, 2018 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Sep 27, 2018 | Sep 24, 2018 |
| 424B5 | Prospectus supplement | Sep 26, 2018 | — |
| 424B2 | Prospectus | Sep 12, 2018 | — |
| 424B2 | Prospectus | Aug 21, 2018 | — |
| 8-K |
Current report
Material agreement
|
Aug 14, 2018 | Aug 10, 2018 |
| 10-Q | Quarterly report | Jul 16, 2018 | May 31, 2018 |
| 424B2 | Prospectus | Jun 1, 2018 | — |
| 424B2 | Prospectus | May 31, 2018 | — |
| 8-K |
Current report
Material agreement
|
May 2, 2018 | Apr 30, 2018 |
| 10-Q | Quarterly report | Apr 5, 2018 | Feb 28, 2018 |
| 8-K |
Current report
Officer or director change
|
Feb 14, 2018 | Feb 1, 2018 |
| 8-K |
Current report
Officer or director change
|
Jan 30, 2018 | Jan 29, 2018 |
| 10-Q | Quarterly report | Jan 16, 2018 | Nov 30, 2017 |
| 8-K |
Current report
Material agreement
|
Dec 19, 2017 | Dec 14, 2017 |
| 10-K | Annual report | Dec 8, 2017 | Aug 31, 2017 |
| NT 10-K | Extension | Nov 29, 2017 | Aug 31, 2017 |
| 8-K |
Current report
Auditor change
|
Nov 13, 2017 | Nov 13, 2017 |
| 8-K |
Current report
Officer or director change
|
Nov 13, 2017 | Nov 12, 2017 |
| 10-Q | Quarterly report | Jul 17, 2017 | May 31, 2017 |
| 8-K |
Current report
Material agreement
|
May 10, 2017 | May 8, 2017 |
| 424B5 | Prospectus supplement | May 10, 2017 | — |
| EFFECT | Filing | Apr 21, 2017 | — |
| CORRESP | Letter to the SEC | Apr 19, 2017 | — |
| 10-Q | Quarterly report | Apr 14, 2017 | Feb 28, 2017 |
| CORRESP | Letter to the SEC | Apr 7, 2017 | — |
| S-3/A | Amendment no. 1 | Apr 7, 2017 | — |
| UPLOAD | Letter from the SEC | Apr 6, 2017 | — |
| S-3 | Shelf registration | Mar 21, 2017 | — |
| 10-K/A | Amended annual report | Mar 15, 2017 | Aug 31, 2016 |
| 10-Q | Quarterly report | Jan 17, 2017 | Nov 30, 2016 |
| 10-K | Annual report | Dec 13, 2016 | Aug 31, 2016 |
| 8-K |
Current report
Officer or director change
|
Dec 13, 2016 | Dec 9, 2016 |
| NT 10-K | Extension | Nov 29, 2016 | Aug 31, 2016 |
| 10-Q | Quarterly report | Jul 13, 2016 | May 31, 2016 |
| 10-Q | Quarterly report | Apr 18, 2016 | Feb 29, 2016 |
| NT 10-Q | Cannabics pharmaceuticals inc. | Apr 15, 2016 | Feb 29, 2016 |
| 10-Q/A | Amended quarterly report | Apr 8, 2016 | Nov 30, 2015 |
| 8-K |
Current report
Auditor change
|
Mar 22, 2016 | Mar 17, 2016 |
| UPLOAD | Letter from the SEC | Mar 15, 2016 | — |
| CORRESP | Letter to the SEC | Feb 22, 2016 | — |
| 8-K |
Current report
Material agreement
|
Feb 22, 2016 | Feb 22, 2016 |
| 8-K |
Current report
Material agreement, Officer or director change
|
Jan 29, 2016 | Jan 25, 2016 |
| 10-Q | Quarterly report | Jan 22, 2016 | Nov 30, 2015 |
| NT 10-Q | Extension | Jan 14, 2016 | Nov 30, 2015 |
| 10-K | Annual report | Jan 7, 2016 | Aug 31, 2015 |
| CORRESP | Letter to the SEC | Dec 23, 2015 | — |
| UPLOAD | Letter from the SEC | Dec 1, 2015 | — |
| NT 10-K | Extension | Nov 30, 2015 | Aug 31, 2015 |
| 10-Q/A | Amended quarterly report | Nov 17, 2015 | May 31, 2015 |
| 10-Q/A | Amended quarterly report | Nov 17, 2015 | Feb 28, 2015 |
| 10-Q/A | Amended quarterly report | Nov 17, 2015 | Nov 30, 2014 |
| 10-K/A | Amended annual report | Oct 23, 2015 | Aug 31, 2014 |
| CORRESP | Letter to the SEC | Oct 20, 2015 | — |
| CORRESP | Letter to the SEC | Oct 14, 2015 | — |
| 8-K |
Current report
Restatement
|
Oct 13, 2015 | Oct 12, 2015 |
| 8-K |
Current report
Material agreement
|
Oct 8, 2015 | Oct 7, 2015 |
| UPLOAD | Letter from the SEC | Sep 15, 2015 | — |
| CORRESP | Letter to the SEC | Aug 19, 2015 | — |
| CORRESP | Letter to the SEC | Jul 28, 2015 | — |
| 10-Q | Quarterly report | Jul 15, 2015 | May 31, 2015 |
| 10-Q/A | Amended quarterly report | Jul 15, 2015 | Feb 28, 2015 |
| CORRESP | Letter to the SEC | Jul 10, 2015 | — |
| UPLOAD | Letter from the SEC | Jun 22, 2015 | — |
| CORRESP | Letter to the SEC | May 28, 2015 | — |
| 8-K |
Current report
Regulation FD disclosure
|
May 28, 2015 | May 27, 2015 |
| CORRESP | Letter to the SEC | May 15, 2015 | — |
| UPLOAD | Letter from the SEC | May 5, 2015 | — |
| CORRESP | Letter to the SEC | Apr 21, 2015 | — |
| 10-Q | Quarterly report | Apr 20, 2015 | Feb 28, 2015 |
| NT 10-Q | Extension | Apr 14, 2015 | Feb 28, 2015 |
| 8-K |
Current report
Officer or director change
|
Apr 9, 2015 | Apr 6, 2015 |
| CORRESP | Letter to the SEC | Apr 7, 2015 | — |
| UPLOAD | Letter from the SEC | Mar 23, 2015 | — |
| 8-K |
Current report
Material agreement
|
Feb 17, 2015 | Feb 15, 2015 |
| 8-K |
Current report
Material agreement
|
Feb 3, 2015 | Jan 29, 2015 |
| 8-K |
Current report
Officer or director change
|
Jan 23, 2015 | Jan 23, 2015 |
| 10-Q | Quarterly report | Jan 20, 2015 | Nov 30, 2014 |
| NT 10-Q | Notice of late filing | Jan 14, 2015 | Nov 30, 2014 |
| 8-K |
Current report
Material agreement
|
Jan 6, 2015 | Dec 31, 2014 |
| 8-K |
Current report
Other events
|
Dec 16, 2014 | Dec 11, 2014 |
| 10-K | Annual report | Dec 15, 2014 | Aug 31, 2014 |
| NT 10-K | Extension | Dec 1, 2014 | Aug 31, 2014 |
| 8-K |
Current report
Material agreement
|
Nov 5, 2014 | Nov 4, 2014 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 1, 2014 | Jul 31, 2014 |
| 8-K |
Current report
Material agreement
|
Jul 25, 2014 | Jul 24, 2014 |
| 10-Q/A | Amended quarterly report | Jul 15, 2014 | May 31, 2014 |
| 10-Q | Quarterly report | Jul 14, 2014 | May 31, 2014 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Jun 20, 2014 | Jun 20, 2014 |
| 8-K |
Current report
Change in control, Officer or director change
|
Apr 30, 2014 | Apr 25, 2014 |
| 8-K |
Current report
Acquisition or sale of assets
|
Apr 8, 2014 | Apr 4, 2014 |
| 10-Q | Quarterly report | Apr 1, 2014 | Feb 28, 2014 |
| EFFECT | Filing | Feb 20, 2014 | — |
| CORRESP | Letter to the SEC | Feb 19, 2014 | — |
| S-1/A | Amended registration statement | Feb 11, 2014 | — |
| S-1/A | Amended registration statement | Jan 31, 2014 | — |
| UPLOAD | Letter from the SEC | Jan 29, 2014 | — |
| S-1/A | Amended registration statement | Jan 24, 2014 | — |
| 10-Q/A | Amended quarterly report | Jan 15, 2014 | Nov 30, 2013 |
| 10-Q | Quarterly report | Jan 14, 2014 | Nov 30, 2013 |
| UPLOAD | Letter from the SEC | Jan 3, 2014 | — |
| S-1 | Registration statement | Dec 11, 2013 | — |
| 10-K/A | Amended annual report | Dec 9, 2013 | Aug 31, 2013 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Dec 9, 2013 | Dec 4, 2013 |
| 10-K/A | Amended annual report | Nov 29, 2013 | Aug 31, 2013 |
| 10-K | Annual report | Nov 29, 2013 | Aug 31, 2013 |
| 8-K |
Current report
Material agreement, Agreement ended, Unregistered share sale
|
Nov 25, 2013 | Nov 20, 2013 |
| 8-K |
Current report
Material agreement
|
Oct 29, 2013 | Oct 24, 2013 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 22, 2013 | Oct 21, 2013 |
| 10-Q | Quarterly report | Jul 15, 2013 | May 31, 2013 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jul 2, 2013 | Jun 28, 2013 |
| 8-K |
Current report
Unregistered share sale
|
Jun 28, 2013 | Jun 24, 2013 |
| 10-Q | Quarterly report | Apr 15, 2013 | Feb 28, 2013 |
| 10-Q | Quarterly report | Jan 14, 2013 | Nov 30, 2012 |
| 10-K | Annual report | Nov 30, 2012 | Aug 31, 2012 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CNBX (OTC)
- Fiscal year ends
- August 31
- Incorporated in
- NV
- Headquarters
- Bethesda, MD
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1343009
- Former names
- Cannabics Pharmaceuticals Inc. (until Mar 16, 2022); American Mining Corp (until May 1, 2014); Thrust Energy Corp. (until May 10, 2011)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.